ID: ALA3110043

Max Phase: Preclinical

Molecular Formula: C35H53N7

Molecular Weight: 571.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)C1CCC(CN2C(=N)N(CCCC[C@H]3CNC(=N)N3CCc3cccnc3)C[C@H]2Cc2ccccc2)CC1

Standard InChI:  InChI=1S/C35H53N7/c1-35(2,3)30-16-14-29(15-17-30)25-42-32(22-27-10-5-4-6-11-27)26-40(34(42)37)20-8-7-13-31-24-39-33(36)41(31)21-18-28-12-9-19-38-23-28/h4-6,9-12,19,23,29-32,37H,7-8,13-18,20-22,24-26H2,1-3H3,(H2,36,39)/t29?,30?,31-,32+/m0/s1

Standard InChI Key:  XDQXQLGRBQNRHS-VJUQQTGUSA-N

Associated Targets(Human)

Nicotinic acetylcholine receptor alpha3/beta4/alpha5 3 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neuronal acetylcholine receptor; alpha4/beta2 3557 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neuronal acetylcholine receptor; alpha3/beta4 1368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 571.86Molecular Weight (Monoisotopic): 571.4362AlogP: 6.02#Rotatable Bonds: 12
Polar Surface Area: 82.34Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 12.22CX LogP: 6.29CX LogD: 1.47
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.27Np Likeness Score: -0.28

References

1. Wu J, Zhang Y, Maida LE, Santos RG, Welmaker GS, LaVoi TM, Nefzi A, Yu Y, Houghten RA, Toll L, Giulianotti MA..  (2013)  Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies.,  56  (24): [PMID:24274400] [10.1021/jm401543h]

Source